Fourth quarter and full year 2018 results
Sanofi delivers 2018 business EPS growth of 5.1% at CER
Fourth quarter and full year 2018 results were reviewed by management during a conference call with the financial community. The presentation was followed by a Q&A session.
In 2019 we will continue to build on the momentum achieved last year
Chief Executive Officer